Immediate Impact
57 standout
Citing Papers
Breast cancer: pathogenesis and treatments
2025 Standout
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Works of Tami Rashal being referenced
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia
2017
First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tami Rashal | 468 | 34 | 219 | 212 | 31 | 627 | |
| A. Krämer | 318 | 65 | 224 | 234 | 30 | 692 | |
| Daniela Intini | 473 | 70 | 296 | 175 | 23 | 688 | |
| Janet L. Lukacs | 377 | 37 | 374 | 128 | 27 | 663 | |
| Claudiu Cotta | 282 | 44 | 182 | 133 | 49 | 623 | |
| Sharon Friedlander | 432 | 115 | 144 | 324 | 34 | 735 | |
| Harald Biersack | 214 | 20 | 194 | 233 | 33 | 546 | |
| Maximilian Merz | 352 | 59 | 313 | 239 | 52 | 642 | |
| Aleksandra Rizo | 306 | 51 | 334 | 191 | 28 | 641 | |
| Mary Gleeson | 335 | 17 | 180 | 183 | 30 | 634 | |
| M Allouche | 301 | 46 | 143 | 122 | 25 | 578 |
All Works
Loading papers...